新地(00016.HK)NOVO LAND第2A期次輪銷售涉223伙 入場費336.09萬元
新地(00016.HK)屯門兆康大型住宅項目NOVO LAND第2A期公布銷售安排,涉223伙,折實平均呎價14,145元,折實售價336.09萬元起。
NOVO LAND第2A期次輪銷售涉223伙,包括一房涉16伙、兩房涉164伙、三房涉30伙、開放式涉13伙,若計及15%折扣,折實售價336.09萬至946.81萬元,折實呎價介乎12,779元至16,580元,市值逾16億元。
次輪銷售將於本周四(15日)晚上8時截票,本周六(17日)上午10時開售。(ca/u)
~
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.